CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 47.32%

Compliant submissions 53

Incompliant submissions 59

Total trials 112

My Organizations' Clinical Trials

Showing 1100 of 1129 entries

View as:

Genes Causing Ebstein's Anomaly

Phase: N/A Priority: Normal

NCT ID: NCT00497705 Org: User:

Start: 07/03/07 End: - Due: -

Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II)

Phase: N/A Priority: Normal

NCT ID: NCT00007085 Org: User:

Start: 09/30/00 End: 12/31/04 Due: 12/31/05

Effects of Chronic Ozone Exposure on Lung Function

Phase: N/A Priority: Normal

NCT ID: NCT00006306 Org: User:

Start: 09/30/99 End: 08/31/04 Due: 08/31/05

Etiologic Risk Factors of Cardiovascular Malformations

Phase: N/A Priority: Normal

NCT ID: NCT00005153 Org: User:

Start: 12/31/80 End: 11/30/98 Due: 11/30/99

Genomics of In-Stent Restenosis

Phase: N/A Priority: Normal

NCT ID: NCT00341562 Org: User:

Start: 09/30/05 End: 07/31/06 Due: 07/31/07

Genomewide Search for Loci Underlying Metabolic Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00074451 Org: User:

Start: 09/30/03 End: 08/31/08 Due: 08/31/09

Stress Reduction and Prevention of Hypertension in Blacks

Phase: N/A Priority: Normal

NCT ID: NCT00005748 Org: User:

Start: 05/31/98 End: 04/30/04 Due: 04/30/05

Antecedents of Bronchopulmonary Dysplasia

Phase: N/A Priority: Normal

NCT ID: NCT00005293 Org: User:

Start: 12/31/88 End: 11/30/90 Due: 11/30/91

Homocysteine and Progression of Atherosclerosis

Phase: N/A Priority: Normal

NCT ID: NCT00005338 Org: User:

Start: 08/31/91 End: 08/31/04 Due: 08/31/05

Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease

Phase: N/A Priority: Normal

NCT ID: NCT04476277 Org: User:

Start: 04/19/21 End: 02/14/23 Due: 02/14/24

Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)

Phase: N/A Priority: Normal

NCT ID: NCT00528203 Org: User:

Start: 08/31/07 End: 09/30/08 Due: 09/30/09

The Effect of Self-regulatory Education on Women With Asthma

Phase: N/A Priority: Normal

NCT ID: NCT00217802 Org: User:

Start: 03/31/00 End: 02/28/07 Due: 02/28/08

Blood Factors and Peripheral Arterial Disease Outcomes

Phase: N/A Priority: Normal

NCT ID: NCT00035776 Org: User:

Start: 01/31/01 End: 12/31/05 Due: 12/31/06

Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives

Phase: N/A Priority: Normal

NCT ID: NCT00005417 Org: User:

Start: 09/30/91 End: 09/30/93 Due: 09/30/94

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Phase: N/A Priority: Normal

NCT ID: NCT06313398 Org: User:

Start: 05/17/24 End: 06/15/29 Due: 06/15/30

Lung Tissue Research Consortium

Phase: N/A Priority: Normal

NCT ID: NCT02988388 Org: User:

Start: 02/23/17 End: 02/21/19 Due: 02/21/20

Biobehavioral Mechanisms of Blood Pressure Regulation

Phase: N/A Priority: Normal

NCT ID: NCT00005366 Org: User:

Start: 09/30/93 End: 08/31/98 Due: 08/31/99

Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT02315586 Org: User:

Start: 01/28/15 End: 02/23/22 Due: 02/23/23

Conditioned Placebo Effects and Treatment of Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT00269269 Org: User:

Start: 09/30/02 End: 07/31/07 Due: 07/31/08

Behavioral and Immunological Factors in Coronary Disease

Phase: N/A Priority: Normal

NCT ID: NCT00037284 Org: User:

Start: 07/31/01 End: 05/31/08 Due: 05/31/09

Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal

NCT ID: NCT00039923 Org: User:

Start: 06/30/02 End: 06/30/05 Due: 06/30/06

Hormone Therapy Effects on CVD Risk Factors

Phase: N/A Priority: Normal

NCT ID: NCT00006313 Org: User:

Start: 06/30/99 End: 06/30/00 Due: 06/30/01

Gene Therapy for the Treatment of Fanconi's Anemia Type C

Phase: N/A Priority: Normal

NCT ID: NCT00001399 Org: User:

Start: 12/03/93 End: 02/11/09 Due: 02/11/10

Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic Access

Phase: N/A Priority: Normal

NCT ID: NCT02280824 Org: User:

Start: 10/30/14 End: 12/28/18 Due: 12/28/19

Validation and Exploration of Sleep and Mood Predictors

Phase: N/A Priority: Normal

NCT ID: NCT00005401 Org: User:

Start: 08/31/95 End: 07/31/99 Due: 07/31/00

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Genes Causing Ebstein's Anomaly	NCT00497705	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2007-07-03	-	-	-	-	2025-07-14
Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II)	NCT00007085	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2000-09-30	2004-12-31	2005-12-31	-	-	2025-07-14
Effects of Chronic Ozone Exposure on Lung Function	NCT00006306	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1999-09-30	2004-08-31	2005-08-31	-	-	2025-07-14
Etiologic Risk Factors of Cardiovascular Malformations	NCT00005153	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1980-12-31	1998-11-30	1999-11-30	-	-	2025-07-14
Genomics of In-Stent Restenosis	NCT00341562	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2005-09-30	2006-07-31	2007-07-31	-	-	2025-07-14
Genomewide Search for Loci Underlying Metabolic Syndrome	NCT00074451	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2003-09-30	2008-08-31	2009-08-31	-	-	2025-07-14
Stress Reduction and Prevention of Hypertension in Blacks	NCT00005748	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1998-05-31	2004-04-30	2005-04-30	-	-	2025-07-14
Antecedents of Bronchopulmonary Dysplasia	NCT00005293	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1988-12-31	1990-11-30	1991-11-30	-	-	2025-07-14
Homocysteine and Progression of Atherosclerosis	NCT00005338	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1991-08-31	2004-08-31	2005-08-31	-	-	2025-07-14
Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease	NCT04476277	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2021-04-19	2023-02-14	2024-02-14	-	-	2025-07-14
Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)	NCT00528203	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2007-08-31	2008-09-30	2009-09-30	-	-	2025-07-14
The Effect of Self-regulatory Education on Women With Asthma	NCT00217802	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2000-03-31	2007-02-28	2008-02-28	-	-	2025-07-14
Blood Factors and Peripheral Arterial Disease Outcomes	NCT00035776	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2001-01-31	2005-12-31	2006-12-31	-	-	2025-07-14
Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives	NCT00005417	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1991-09-30	1993-09-30	1994-09-30	-	-	2025-07-14
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling	NCT06313398	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2024-05-17	2029-06-15	2030-06-15	-	-	2025-07-14
Lung Tissue Research Consortium	NCT02988388	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2017-02-23	2019-02-21	2020-02-21	-	-	2025-07-14
Biobehavioral Mechanisms of Blood Pressure Regulation	NCT00005366	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1993-09-30	1998-08-31	1999-08-31	-	-	2025-07-14
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis	NCT02315586	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2015-01-28	2022-02-23	2023-02-23	-	-	2025-07-14
Conditioned Placebo Effects and Treatment of Hypertension	NCT00269269	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2002-09-30	2007-07-31	2008-07-31	-	-	2025-07-14
Behavioral and Immunological Factors in Coronary Disease	NCT00037284	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2001-07-31	2008-05-31	2009-05-31	-	-	2025-07-14
Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria	NCT00039923	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2002-06-30	2005-06-30	2006-06-30	-	-	2025-07-14
Hormone Therapy Effects on CVD Risk Factors	NCT00006313	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1999-06-30	2000-06-30	2001-06-30	-	-	2025-07-14
Gene Therapy for the Treatment of Fanconi's Anemia Type C	NCT00001399	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1993-12-03	2009-02-11	2010-02-11	-	-	2025-07-14
Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic Access	NCT02280824	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2014-10-30	2018-12-28	2019-12-28	-	-	2025-07-14
Validation and Exploration of Sleep and Mood Predictors	NCT00005401	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1995-08-31	1999-07-31	2000-07-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance